CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 26 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 275,000 | $1,106,000 | 0.63% |
| Invesco Private Capital | 116,316 | $468,000 | 0.03% |
| Investors Capital Advisory Services | 10,150 | $40,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 12,004 | $48,000 | 0.01% |
| Allianz Asset Management GmbH | 559,207 | $2,248,000 | 0.00% |
| Virtu KCG Holdings LLC | 38,241 | $153,000 | 0.00% |
| Jane Street Holding, LLC | 13,555 | $54,000 | 0.00% |
| NORTHERN TRUST CORP | 28,642 | $115,000 | 0.00% |
| CREDIT SUISSE AG/ | 28,241 | $114,000 | 0.00% |
| CITIGROUP INC | 1,310 | $5,000 | 0.00% |